Children’s Claratyne: clarity in kids’ hayfever
Allergic rhinitis a common condition with pervasive impacts on children. Allergic rhinitis (AR) or hayfever, is common, affecting up to 40% of children.1 AR and asthma commonly coexist, with AR …
Bone remodelling and osteoporosis revisited
Back to Basics with Peter Carroll The aim of this series of articles is to revisit and discuss some fundamental pharmacological, physiological and therapeutic concepts with the overall objective of …
The evolving role of pharmacists in implementing treat-to-target gout management
Gout is a common and complex chronic inflammatory arthritis requiring pharmacist expertise to help patients prevent and treat acute flares, manage long-term urate therapy and address risk factors. By Dr …
Chronic hand eczema: a pharmacist’s guide to novel therapy
Chronic hand eczema is a particularly challenging condition for patients who experience ongoing inflammation, itch and pain. Potent topical corticosteroids are often required to control flares, but chronic use may …
Every consultation counts: pharmacist-led counselling, nasal technique and follow-up in allergic rhinitis
A deep dive on what pharmacists can ask, explain, demonstrate and review to improve adherence and outcomes for this highly prevalent condition, including the adjunct use of nasal saline to …
Optimising calcium homeostasis: the interplay of vitamin D, K2, magnesium and calcium in bone density and vascular calcification risk
This article explores the synergistic physiological action of calcium, vitamin D, vitamin K2 and magnesium in bone and cardiovascular health and how supplementation may be beneficial for patients with inadequate …
How risk management supports clinical governance
USING THE PDL RISK MANAGEMENT GUIDE FOR PHARMACISTS This series introduces pharmacists to the PDL Risk Management Guide for Pharmacists, and how it can be used in everyday pharmacy practice …
Osteoporosis screening, prevention, treatment and switching between therapies
Switching between osteoporosis medicines is not a simple handover, it can determine whether treatment gains are protected or fracture risk rebounds. This article equips pharmacists to recognise when therapy switching …